The ITA notifies weightlifter Brenda Uchenna Bosah of an apparent anti-doping rule violation
The International Testing Agency (ITA), leading an independent anti-doping program for the International Weightlifting Federation (IWF), reports that it has notified Nigerian weightlifter Brenda Uchenna Bosah of an Adverse Analytical Finding (AAF) for exogenous origin of testosterone and adiol(s).
The ITA reports that a sample collected from Brenda Uchenna Bosah on 2 March 2026 during an out-of-competition anti-doping control has returned an AAF¹ for exogenous testosterone and adiol(s).
These substances are listed under class S1.1 Anabolic Androgenic Steroids according to the World Anti-Doping Agency (WADA) Prohibited List. They are prohibited at all times (in- and out-of-competition) and are classified as non-specified substances. These substances have potent muscle-building and strength-increasing properties.
The athlete has been informed of the case and has the right to request the analysis of the B-sample.
If the B-sample analysis is requested and confirms the result of the A-sample, the case will be considered as a confirmed anti-doping rule violation. If the B-sample analysis is not requested, the case will also go ahead as a confirmed anti-doping rule violation. The athlete will have the opportunity to present her explanations for the result.
Further, in accordance with the World Anti-Doping Code and article 7.4.1 of the IWF anti-doping rules, a mandatory provisional suspension has been imposed on the athlete. The athlete has the right to challenge the provisional suspension and ask for its lifting.
Pursuant to the IWF’s delegation of its anti-doping program to the ITA, the prosecution of the case is being handled entirely by the ITA. Given that the case is underway, there will be no further comments made.
The original press release can be found here:https://ita.sport/news/the-ita-notifies-weightlifter-brenda-uchenna-bosah-of-an-apparent-anti-doping-rule-violation/
